Showing results (121-130 of 186) with videos related to

Sort By:
Pageof 19
Diagnostic Microbiology and Infectious Disease|January 5, 2002
Effect of routine use of a multiplex PCR for detection of vanA- and vanB- mediated enterococcal resistance on accuracy, costs and earlier reportingA Petrich, K Luinstra, B Page, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999Xiaocheng Wu, Vivien W Chen, Jim Martin, et al.
Southern Medical Journal|June 1, 1994
Pernicious anemia manifesting as angina pectorisP J Asimacopoulos, M D Groves, D K Fischer, et al.
American Journal of Obstetrics and Gynecology|January 1, 1991
The accuracy of clinical findings and laparoscopy in pelvic inflammatory diseaseJ Sellors, J Mahony, C Goldsmith, et al.
Journal of AOAC International|October 11, 2002
N-nitroso compounds and mutagens in Chinese fermented (sour) corn pancakesFrank D Groves, Haleem Issaq, Stephen Fox, et al.
Diabetes Research and Clinical Practice|March 21, 2015
Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomyDuke Appiah, Stephen J Winters, Matthew A Allison, et al.
Applied and Environmental Microbiology|July 17, 2012
Molecular characterization of commensal Escherichia coli adapted to different compartments of the porcine gastrointestinal tractSam Abraham, David M Gordon, James Chin, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|February 21, 2017
Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experienceRory Richard Mayer, Benjamin Jay Frankfort, Ben A Strickland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Kenneth R Hess, et al.
Pageof 19